Validation of Ella Platform for Serum Nfl And GFAP Measures In Multiple Sclerosis Patients

CompletedOBSERVATIONAL
Enrollment

664

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Multiple Sclerosis
Interventions
OTHER

Biomarker quantification

Patient blood samples will be tested on 2 different platforms

Trial Locations (10)

Unknown

CHU Clermont-Ferrand, Clermont-Ferrand

Hôpital Henri Mondor, Créteil

CHRU Lille, Lille

Hospices Civils de Lyon, Lyon

CHU Gui de Chauliac, Montpellier

CHU de Nantes,, Nantes

Centre Hospitalier Universitaire Pasteur 2, Nice

CHU de Nîmes, Nîmes

Hôpital Pitié-Salpêtrière, Paris

CHU de Strasbourg, Strasbourg

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER